Dinutuxumab Beta Plus Conventional Chemotherapy for Relapsed/Refractory High-Risk Neuroblastoma: A Single Centre Experience

被引：0
|
作者：
Olgun, N. [1 ]
Cecen, R. E. [1 ]
Ince, D. [1 ]
Onal, A. [1 ]
Baysal, B. [2 ]
Akyol, S. [1 ]
Ozdogan, O. [3 ]
Guleryuz, H. [4 ]
Aktas, S. [1 ]
Ozer, E. [5 ]
机构：
[1] Dokuz Eylul Univ, Inst Oncol, Izmir, Turkey
[2] Marmara Univ, Educ & Res Hosp, Pediat Hematol & Oncol, Istanbul, Turkey
[3] Dokuz Eylul Univ, Nucl Med, Izmir, Turkey
[4] Dokuz Eylul Univ, Radiodiagnost, Izmir, Turkey
[5] Dokuz Eylul Univ, Pathol, Izmir, Turkey
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PV0129
引用
收藏
页码：S215 / S215
页数：1
相关论文
共 50 条
  • [21] Phase I study of bortezomib in combination with irinotecan in patients with relapsed/refractory high-risk neuroblastoma
    Mody, Rajen
    Zhao, Lili
    Yanik, Gregory Anthony
    Opipari, Valerie
    PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [22] Retrospective analysis of relapsed abdominal high-risk neuroblastoma
    Duebbers, Martin
    Simon, Thorsten
    Berthold, Frank
    Fischer, Janina
    Volland, Ruth
    Hero, Barbara
    Cernaianu, Grigore
    JOURNAL OF PEDIATRIC SURGERY, 2018, 53 (03) : 558 - 566
  • [23] SYNERGISTIC ANTITUMOR INTERACTIONS BETWEEN PANOBINOSTAT AND CONVENTIONAL CHEMOTHERAPY DRUGS IN HIGH-RISK NEUROBLASTOMA
    Wang, G.
    Jolly, P.
    Taub, J.
    Ge, Y.
    Wang, Z.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 120 - 121
  • [24] DFMO Maintains Remission in Relapsed/Refractory High Risk Neuroblastoma
    Sholler, Giselle Saulnier
    Ferguson, William
    Bergendahl, Genevieve
    Bond, Jeffrey
    Neville, Kathleen
    Eslin, Don
    Brown, Valerie
    Roberts, William
    Wada, Randy
    Oesterheld, Javier
    Mitchell, Deanna
    Foley, Jessica
    Zage, Peter
    Rawwas, Jawhar
    Sencer, Susan
    Kraveka, Jacqueline
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S46 - S47
  • [25] Patterns of improvement following initial response in patients treated with naxitamab for relapsed/refractory high-risk neuroblastoma
    Mora, Jaume
    Chan, Godfrey C.
    Morgenstern, Daniel A.
    Amoroso, Loredana
    Nysom, Karsten
    Faber, Joerg
    Wingerter, Arthur
    Bear, Melissa
    Rubio-San-Simon, Alba
    Tornoe, Karen
    Duering, Maria
    Kushner, Brian H.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] SALVAGE REGIMENT WITH FLAT FOR REFRACTORY AND RELAPSED AML: EXPERIENCE A SINGLE CENTRE
    Salamanca, A.
    Madrigal, D.
    Saldana, R.
    Martin, E.
    Garzon, S.
    HAEMATOLOGICA, 2016, 101 : 681 - 681
  • [27] Treatment of Relapsed/Refractory Langerhans Cell Histiocytosis: A Single Centre Experience
    Dua, Vikas
    Yadav, Satya Prakash
    Sachdeva, Anupam
    INDIAN JOURNAL OF PEDIATRICS, 2014, 81 (03): : 315 - 316
  • [28] Bendamustine in relapsed or refractory indolent lymphoproliferative disorders: A single centre experience
    Nga, E. L. M.
    Sadullah, S.
    Gomez, C. C.
    Braithwaite, J. E. G.
    EJC SUPPLEMENTS, 2010, 8 (04): : 23 - 24
  • [29] Bendamustine in relapsed or refractory indolent lymphoproliferative disorders - a single centre experience
    Nga, E. L. M.
    Gomez, C. A.
    Braithwaite, J. E. G.
    Sadullah, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 42 - 42
  • [30] Treatment of Relapsed/Refractory Langerhans Cell Histiocytosis: A Single Centre Experience
    Vikas Dua
    Satya Prakash Yadav
    Anupam Sachdeva
    The Indian Journal of Pediatrics, 2014, 81 : 315 - 316
12345